• Title/Summary/Keyword: nicotine replacement therapy

Search Result 14, Processing Time 0.017 seconds

Success Factors of Smoking Cessation among new enrollees and re-enrollees in Smoking Cessation Clinics at Public Health Centers (보건소 금연클리닉의 신규등록자와 재등록자의 금연성공 요인 비교 분석)

  • Lee, Ki Ho;Chung, Young Chul;Kim, Kye Hyun
    • Journal of Digital Convergence
    • /
    • v.12 no.1
    • /
    • pp.445-455
    • /
    • 2014
  • This study has targeted to comparatively analyze smoking cessation success rates and success factors among new enrollees and re-enrollees in Smoking Cessation Clinics for its efficient operation. A total of 319,908 smokers who were enrolled in the Smoking Cessation Clinics in one of 253 public health centers across the nation for more than 6 months from July 16, 2009 to July 15, 2010 were examined. According to the comparative analysis, the following results have been obtained. According to the results, it has been confirmed that it is necessary to determine why smoking cessation success rates are low and take additional efforts to increase the rates for the effective operation of smoking cessation clinics. In addition, smoking cessation success rates were higher when only BT(Behavior Therapy) was given than when both BT and NRT(Nicotine Replacement Therapy) were provided to new enrollees while they were lower when only BT was provided than when both BT and NRT were given to re-enrollees. Therefore, it is necessary to provide differentiated service types depending on the type of enrollment. Hence, it is also required for the government to take various approaches in terms of a direction for a smoking cessation policy.

The effectiveness and safety of acupuncture combination treatment on smoking cessation: A protocol for systematic review (금연에 대한 침술 병용 치료의 효과 및 안전성 : 체계적 검토를 위한 프로토콜)

  • In Suh Choi;Won-Suk Sung;Min-gi Jo;Jung-Hyun Kim;Yeon-Cheol Park;Eun-Jung Kim;Yong-Hyeon Baek;Geun-Woo Kim;Byung-Kwan Seo
    • Journal of Convergence Korean Medicine
    • /
    • v.3 no.1
    • /
    • pp.5-13
    • /
    • 2022
  • Objectives: Smoking had a long negative impact on public health. The ingredients of a cigarette are major risk factors for several diseases. Owing to the problems about economic and quality of life, we need to ensure smoking cessation (SC). There are several approaches for SC including pharmacological therapy, nicotine replacement therapy, education, and behavioral intervention. However, due to some limitations, other alternative approaches are gaining popularity. Acupuncture has been reported to have few side effects and be more effective than some conventional treatments in several articles. However, there are no systematic reviews on the comparison of acupuncture combination treatment with other conventional monotherapies. Methods: Randomized controlled trials that used acupuncture as an adjunct treatment for SC will be searched and data will be summarized according to the predefined criteria. The primary outcome will be the abstinence rate, and secondary outcomes will be adverse events and biochemical indicators. We will use Review Manager to perform a meta-analysis, Cochrane Collaboration Risk of Bias tool for the risk of bias assessment, and the Grades of Recommendation, Assessment, Development and Evaluation approach to determine the quality of evidence. We will investigate the efficacy and safety of acupuncture combination treatment for SC with this study. Ethics and dissemination: This study will provide reliable clinical evidence on additional effect of acupuncture on smoking cessation. We will publish our results in a peer-review journal.

Seven-Day Continuous Abstinence Rate from Smoking at 1, 2, or 3 Years after the Use of Varenicline

  • Kim, Jin Se;Jang, Ju Young;Park, Eun Hye;Lee, Joo Young;Gu, Kang Mo;Jung, Jae Woo;Choi, Jae Chol;Shin, Jong Wook;Park, In Won;Choi, Byoung Whui;Kim, Jae Yeol
    • Tuberculosis and Respiratory Diseases
    • /
    • v.78 no.2
    • /
    • pp.92-98
    • /
    • 2015
  • Background: Varenicline, a selective partial agonist/antagonist of the ${\alpha}4{\beta}2$ nicotinic receptor, has proven effectiveness for smoking cessation by several randomized, controlled trials. Because few studies have evaluated the long-term efficacy of varenicline, we tried to evaluate the smoking status of varenicline users up to 3 years after the initial prescription of the drug. Methods: We interviewed varenicline users who were prescribed the drug from June 2007 to May 2010 by telephone, from June 2010 to May 2011. Results: One-hundred and thirty-three of 250 varenicline users (53.2%) were available for the survey. Seven-day continuous abstinence from smoking was adhered to by 17 of 39 respondents (43.6%) at 1 year, and 11 of 36 (30.6%) and 19 of 58 (32.8%) at 2 and 3 years since the first use of varenicline, respectively. Compared to current smokers, successful quitters were older (55.0 years vs. 49.9 years, p=0.01), had better compliance to the 12-week course (27.7 vs. 9.3%, p=0.01), and had taken varenicline longer (10.1 vs. 5.9 weeks, p=0.01). Fifty-four of 71 current smokers (76.1%) were willing to stop smoking in the near future. The preferred ways to cease smoking were will-power (48.1%), varenicline (25.9%), nicotine replacement therapy (11.1%), and others (14.9%). Conclusion: Smokers should be encouraged to stick to the proven way for recommended period of time for successful cessation of smoking.